{"status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved.", "response": {"docs": [{"word_count": 711, "slideshow_credits": null, "multimedia": [], "news_desk": "Business/Financial Desk", "pub_date": "1999-05-03T00:00:00Z", "source": "The New York Times", "web_url": "http://www.nytimes.com/1999/05/03/business/diet-drug-may-face-a-tough-sell-at-hmo-s.html", "blog": [], "_id": "4fd1ff408eb7c8105d760e52", "headline": {"main": "Diet Drug May Face A Tough Sell At H.M.O.'s"}, "subsection_name": null, "abstract": "Several managed care companies categorize Xenical, newly approved weight-loss drug, as life style product that they will cover only in exceptional cases, for overweight people at risk of cardiovascular problems or other serious problems; analysts expect many people to pay for Xenical themselves, at cost of $4 or $5 per day (M)", "section_name": "Health; Business", "byline": {"original": "By MILT FREUDENHEIM", "person": [{"rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM", "role": "reported", "organization": ""}]}, "print_page": "6", "document_type": "article", "type_of_material": "News", "keywords": [{"value": "WEIGHT", "name": "subject"}, {"value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE", "name": "subject"}, {"value": "HEALTH INSURANCE", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "PRICES (FARES, FEES AND RATES)", "name": "subject"}, {"value": "XENICAL (DRUG)", "name": "subject"}], "lead_paragraph": "People who hope to slim down with the help of Xenical, a newly approved weight-loss drug, may have to pay for it themselves. A number of managed care companies are categorizing Xenical as a life style product that they will cover only in exceptional cases -- for overweight people at risk for cardiovascular problems, or those with diabetes, breathing problems or brittle bones. Even so, analysts said, many people are likely to pay the $4 or $5 a day themselves needed to buy Xenical, a treatment made by Roche Holding A.G. of Switzerland. Analysts projected peak worldwide sales of the drug at $600 million to as much as $3 billion a year.", "snippet": "People who hope to slim down with the help of Xenical, a newly approved weight-loss drug, may have to pay for it themselves. A number of managed care companies are categorizing Xenical as a life style product that they will cover only in exceptional..."}], "meta": {"offset": 0, "hits": 1, "time": 224}}}